197 related articles for article (PubMed ID: 28035420)
1. Argininosuccinate lyase interacts with cyclin A2 in cytoplasm and modulates growth of liver tumor cells.
Hung YH; Huang HL; Chen WC; Yen MC; Cho CY; Weng TY; Wang CY; Chen YL; Chen LT; Lai MD
Oncol Rep; 2017 Feb; 37(2):969-978. PubMed ID: 28035420
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of argininosuccinate lyase inhibits cancer growth via cyclin A2 and nitric oxide.
Huang HL; Hsu HP; Shieh SC; Chang YS; Chen WC; Cho CY; Teng CF; Su IJ; Hung WC; Lai MD
Mol Cancer Ther; 2013 Nov; 12(11):2505-16. PubMed ID: 23979921
[TBL] [Abstract][Full Text] [Related]
3. Silencing of argininosuccinate lyase inhibits colorectal cancer formation.
Huang HL; Chen WC; Hsu HP; Cho CY; Hung YH; Wang CY; Lai MD
Oncol Rep; 2017 Jan; 37(1):163-170. PubMed ID: 27840980
[TBL] [Abstract][Full Text] [Related]
4. Argininosuccinate lyase is a potential therapeutic target in breast cancer.
Huang HL; Chen WC; Hsu HP; Cho CY; Hung YH; Wang CY; Lai MD
Oncol Rep; 2015 Dec; 34(6):3131-9. PubMed ID: 26397737
[TBL] [Abstract][Full Text] [Related]
5. miR-451 inhibits cell proliferation in human hepatocellular carcinoma through direct suppression of IKK-β.
Li HP; Zeng XC; Zhang B; Long JT; Zhou B; Tan GS; Zeng WX; Chen W; Yang JY
Carcinogenesis; 2013 Nov; 34(11):2443-51. PubMed ID: 23740840
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation and subcellular localization of hnRNP A2/B1 in the development of hepatocellular carcinoma.
Cui H; Wu F; Sun Y; Fan G; Wang Q
BMC Cancer; 2010 Jul; 10():356. PubMed ID: 20604928
[TBL] [Abstract][Full Text] [Related]
7. FAM9C plays an anti-apoptotic role through activation of the PI3K/Akt pathway in human hepatocellular carcinoma.
Zhou JD; Shen F; Ji JS; Zheng K; Huang M; Wu JC
Oncol Rep; 2013 Sep; 30(3):1275-84. PubMed ID: 23836295
[TBL] [Abstract][Full Text] [Related]
8. miR-922 regulates CYLD expression and promotes the cell proliferation of human hepatocellular carcinoma.
Liu J; Su Z; Zeng Y; Zhang H; Yang S; Liu G
Oncol Rep; 2017 Mar; 37(3):1445-1450. PubMed ID: 28184924
[TBL] [Abstract][Full Text] [Related]
9. Reduced expression of argininosuccinate lyase is closely associated with postresectional survival in hepatocellular carcinoma: an immunohistochemistry study of 61 cases.
Yang H; Zhai G; Ji X; Su J; Lin M
Appl Immunohistochem Mol Morphol; 2012 Dec; 20(6):602-6. PubMed ID: 22531684
[TBL] [Abstract][Full Text] [Related]
10. SND1 affects proliferation of hepatocellular carcinoma cell line SMMC-7721 by regulating IGFBP3 expression.
Yin J; Ding J; Huang L; Tian X; Shi X; Zhi L; Song J; Zhang Y; Gao X; Yao Z; Jing X; Yang J
Anat Rec (Hoboken); 2013 Oct; 296(10):1568-75. PubMed ID: 23878061
[TBL] [Abstract][Full Text] [Related]
11. Extracellular HSP70-peptide complexes promote the proliferation of hepatocellular carcinoma cells via TLR2/4/JNK1/2MAPK pathway.
Zhe Y; Li Y; Liu D; Su DM; Liu JG; Li HY
Tumour Biol; 2016 Oct; 37(10):13951-13959. PubMed ID: 27492456
[TBL] [Abstract][Full Text] [Related]
12. miR-217 suppresses proliferation, migration, and invasion promoting apoptosis via targeting MTDH in hepatocellular carcinoma.
Zhang M; Li M; Li N; Zhang Z; Liu N; Han X; Liu Q; Liao C
Oncol Rep; 2017 Mar; 37(3):1772-1778. PubMed ID: 28184926
[TBL] [Abstract][Full Text] [Related]
13. MiR-384 regulated IRS1 expression and suppressed cell proliferation of human hepatocellular carcinoma.
Lai YY; Shen F; Cai WS; Chen JW; Feng JH; Cao J; Xiao HQ; Zhu GH; Xu B
Tumour Biol; 2016 Oct; 37(10):14165-14171. PubMed ID: 27542674
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-105 suppresses cell proliferation and inhibits PI3K/AKT signaling in human hepatocellular carcinoma.
Shen G; Rong X; Zhao J; Yang X; Li H; Jiang H; Zhou Q; Ji T; Huang S; Zhang J; Jia H
Carcinogenesis; 2014 Dec; 35(12):2748-55. PubMed ID: 25280563
[TBL] [Abstract][Full Text] [Related]
15. Survivin-mediated cancer cell migration through GRP78 and epithelial-mesenchymal transition (EMT) marker expression in Mahlavu cells.
Tai CJ; Chin-Sheng H; Kuo LJ; Wei PL; Lu HH; Chen HA; Liu TZ; Liu JJ; Liu DZ; Ho YS; Wu CH; Chang YJ
Ann Surg Oncol; 2012 Jan; 19(1):336-43. PubMed ID: 21516372
[TBL] [Abstract][Full Text] [Related]
16. Histone deacetylase inhibitor suberoylanilide hydroxamic acid suppresses the pro-oncogenic effects induced by hepatitis B virus pre-S2 mutant oncoprotein and represents a potential chemopreventive agent in high-risk chronic HBV patients.
Hsieh YH; Su IJ; Yen CJ; Tsai TF; Tsai HW; Tsai HN; Huang YJ; Chen YY; Ai YL; Kao LY; Hsieh WC; Wu HC; Huang W
Carcinogenesis; 2013 Feb; 34(2):475-85. PubMed ID: 23172669
[TBL] [Abstract][Full Text] [Related]
17. CD147 regulates cancer migration via direct interaction with Annexin A2 and DOCK3-β-catenin-WAVE2 signaling.
Cui HY; Wang SJ; Miao JY; Fu ZG; Feng F; Wu J; Yang XM; Chen ZN; Jiang JL
Oncotarget; 2016 Feb; 7(5):5613-29. PubMed ID: 26716413
[TBL] [Abstract][Full Text] [Related]
18. TREM-1, an inflammatory modulator, is expressed in hepatocellular carcinoma cells and significantly promotes tumor progression.
Duan M; Wang ZC; Wang XY; Shi JY; Yang LX; Ding ZB; Gao Q; Zhou J; Fan J
Ann Surg Oncol; 2015 Sep; 22(9):3121-9. PubMed ID: 25465376
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of WWP1 promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma.
Zhang XF; Chao J; Pan QZ; Pan K; Weng DS; Wang QJ; Zhao JJ; He J; Liu Q; Jiang SS; Chen CL; Zhang HX; Xia JC
Oncotarget; 2015 Dec; 6(38):40920-33. PubMed ID: 26506518
[TBL] [Abstract][Full Text] [Related]
20. ELK3 promotes the migration and invasion of liver cancer stem cells by targeting HIF-1α.
Lee JH; Hur W; Hong SW; Kim JH; Kim SM; Lee EB; Yoon SK
Oncol Rep; 2017 Feb; 37(2):813-822. PubMed ID: 27959451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]